v3.26.1
Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2026
Accrued Expenses [Abstract]
Accrued Expenses
Accrued expenses included the following:
June 30,
2026
December 31,
2025
Incentive and other compensation costs
$
762,526
870,910
Clinical trial costs
179,591
259,293
Director fees
72,944
71,250
Other
18,651
64,320
Accrued expenses
$
1,033,712
1,265,773
X
- References
No definition available.
+ Details
Name:
us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details
Name:
us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:
us-gaap_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration